Ignite Creation Date:
2025-12-25 @ 2:25 AM
Ignite Modification Date:
2025-12-28 @ 12:08 AM
Study NCT ID:
NCT06669234
Status:
RECRUITING
Last Update Posted:
2025-11-25
First Post:
2024-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Safety and Tolerability Study of ALN-F1202 in Healthy Adults
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-03-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-07-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-30
First Submit QC Date:
None
Study First Post Date:
2024-11-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-20
Last Update Post Date:
2025-11-25
Last Update Post Date Type:
ESTIMATED